-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Century Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
- Century Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.5M, a 6.64% increase year-over-year.
- Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.6K, a 37.1% increase from 2022.
- Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.7K, a 99.8% decline from 2021.
- Century Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.66M, a 432% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)